Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct;9(10):576-89.
doi: 10.1038/nrcardio.2012.109. Epub 2012 Jul 31.

Diagnosis and management of Chagas disease and cardiomyopathy

Antonio L Ribeiro  1 , Maria P Nunes, Mauro M Teixeira, Manoel O C Rocha
Affiliations
Review

Diagnosis and management of Chagas disease and cardiomyopathy

Antonio L Ribeiro et al. Nat Rev Cardiol. 2012 Oct.

Abstract

Chagas cardiomyopathy is the most severe and life-threatening manifestation of human Chagas disease--a 'neglected' tropical disease caused by the protozoan parasite Trypanosoma cruzi. The disease is endemic in all continental Latin American countries, but has become a worldwide problem because of migration of infected individuals to developed countries, mainly in Europe and North America. Chagas cardiomyopathy results from the combined effects of persistent parasitism, parasite-driven tissue inflammation, microvascular and neurogenic dysfunction, and autoimmune responses triggered by the infection. Clinical presentation varies widely according to the extent of myocardial damage, and manifests mainly as three basic syndromes that can coexist in an individual patient: heart failure, cardiac arrhythmia, and thromboembolism. NYHA functional class, left ventricular systolic function, and nonsustained ventricular tachycardia are important prognostic markers of the risk of death. Management of Chagas cardiomyopathy focuses on the treatment of the three main syndromes. The use of β-blockers in patients with Chagas disease and heart failure is safe, well tolerated, and should be encouraged. Most specialists and international institutions now recommend specific antitrypanosomal treatment of patients with chronic Chagas disease, even in the absence of evidence obtained from randomized clinical trials. Further research on the management of patients with Chagas cardiomyopathy is necessary.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Adv Parasitol. 2011;76:129-52 - PubMed
    1. Vasc Health Risk Manag. 2010 Aug 09;6:593-601 - PubMed
    1. Arq Bras Cardiol. 2001 Jul;77(1):59-62 - PubMed
    1. Nature. 2010 Jun 24;465(7301):S12-5 - PubMed
    1. Nature. 2010 Jun 24;465(7301):S6-7 - PubMed

Publication types

LinkOut - more resources